Global Biosimulation Market is anticipated to grow 1.8x by the end forecast period with a CAGR of over 16.2% during the forecast period (2022 to 2030). Growing pressure to cut healthcare spending, rising demand for biosimilars due to their cost-effectiveness, rising incidence of various diseases, an increasing number of off-patented drugs, positive …
Read More »